United States Anti-angiogenic Agent Market Report 2016

United States Anti-angiogenic Agent Market Report 2016

1 Anti-angiogenic Agent Overview

1.1 Product Overview and Scope of Anti-angiogenic Agent

1.2 Classification of Anti-angiogenic Agent

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Anti-angiogenic Agent

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Anti-angiogenic Agent (2011-2021)

1.4.1 United States Anti-angiogenic Agent Sales and Growth Rate (2011-2021)

1.4.2 United States Anti-angiogenic Agent Revenue and Growth Rate (2011-2021)

2 United States Anti-angiogenic Agent Competition by Manufacturers

2.1 United States Anti-angiogenic Agent Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Anti-angiogenic Agent Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Anti-angiogenic Agent Average Price by Manufactures (2015 and 2016)

2.4 Anti-angiogenic Agent Market Competitive Situation and Trends

2.4.1 Anti-angiogenic Agent Market Concentration Rate

2.4.2 Anti-angiogenic Agent Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Anti-angiogenic Agent Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Anti-angiogenic Agent Sales and Market Share by Type (2011-2016)

3.2 United States Anti-angiogenic Agent Revenue and Market Share by Type (2011-2016)

3.3 United States Anti-angiogenic Agent Price by Type (2011-2016)

3.4 United States Anti-angiogenic Agent Sales Growth Rate by Type (2011-2016)

4 United States Anti-angiogenic Agent Sales (Volume) by Application (2011-2016)

4.1 United States Anti-angiogenic Agent Sales and Market Share by Application (2011-2016)

4.2 United States Anti-angiogenic Agent Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Anti-angiogenic Agent Manufacturers Profiles/Analysis

5.1 Pfizer, Inc. (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Anti-angiogenic Agent Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Eli Lilly and Company (USA)

5.2.2 Anti-angiogenic Agent Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Eli Lilly and Company (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Bayer HealthCare Pharmaceuticals, Inc. (USA)

5.3.2 Anti-angiogenic Agent Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Abbott Laboratories (USA)

5.4.2 Anti-angiogenic Agent Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Abbott Laboratories (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 AstraZeneca Plc. (UK)

5.5.2 Anti-angiogenic Agent Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 AstraZeneca Plc. (UK) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Meditrina Pharmaceuticals, Inc. (US)

5.6.2 Anti-angiogenic Agent Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Neurocrine Biosciences, Inc. (US)

5.7.2 Anti-angiogenic Agent Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 AEterna Zentaris, Inc. (Canada)

5.8.2 Anti-angiogenic Agent Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

6 Anti-angiogenic Agent Manufacturing Cost Analysis

6.1 Anti-angiogenic Agent Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Anti-angiogenic Agent

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Anti-angiogenic Agent Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Anti-angiogenic Agent Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Anti-angiogenic Agent Market Forecast (2016-2021)

10.1 United States Anti-angiogenic Agent Sales, Revenue Forecast (2016-2021)

10.2 United States Anti-angiogenic Agent Sales Forecast by Type (2016-2021)

10.3 United States Anti-angiogenic Agent Sales Forecast by Application (2016-2021)

10.4 Anti-angiogenic Agent Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Anti-angiogenic Agent

Table Classification of Anti-angiogenic Agent

Figure United States Sales Market Share of Anti-angiogenic Agent by Type in 2015

Table Application of Anti-angiogenic Agent

Figure United States Sales Market Share of Anti-angiogenic Agent by Application in 2015

Figure United States Anti-angiogenic Agent Sales and Growth Rate (2011-2021)

Figure United States Anti-angiogenic Agent Revenue and Growth Rate (2011-2021)

Table United States Anti-angiogenic Agent Sales of Key Manufacturers (2015 and 2016)

Table United States Anti-angiogenic Agent Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Anti-angiogenic Agent Sales Share by Manufacturers

Figure 2016 Anti-angiogenic Agent Sales Share by Manufacturers

Table United States Anti-angiogenic Agent Revenue by Manufacturers (2015 and 2016)

Table United States Anti-angiogenic Agent Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Anti-angiogenic Agent Revenue Share by Manufacturers

Table 2016 United States Anti-angiogenic Agent Revenue Share by Manufacturers

Table United States Market Anti-angiogenic Agent Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Anti-angiogenic Agent Average Price of Key Manufacturers in 2015

Figure Anti-angiogenic Agent Market Share of Top 3 Manufacturers

Figure Anti-angiogenic Agent Market Share of Top 5 Manufacturers

Table United States Anti-angiogenic Agent Sales by Type (2011-2016)

Table United States Anti-angiogenic Agent Sales Share by Type (2011-2016)

Figure United States Anti-angiogenic Agent Sales Market Share by Type in 2015

Table United States Anti-angiogenic Agent Revenue and Market Share by Type (2011-2016)

Table United States Anti-angiogenic Agent Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Anti-angiogenic Agent by Type (2011-2016)

Table United States Anti-angiogenic Agent Price by Type (2011-2016)

Figure United States Anti-angiogenic Agent Sales Growth Rate by Type (2011-2016)

Table United States Anti-angiogenic Agent Sales by Application (2011-2016)

Table United States Anti-angiogenic Agent Sales Market Share by Application (2011-2016)

Figure United States Anti-angiogenic Agent Sales Market Share by Application in 2015

Table United States Anti-angiogenic Agent Sales Growth Rate by Application (2011-2016)

Figure United States Anti-angiogenic Agent Sales Growth Rate by Application (2011-2016)

Table Pfizer, Inc. (US) Basic Information List

Table Pfizer, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer, Inc. (US) Anti-angiogenic Agent Sales Market Share (2011-2016)

Table Eli Lilly and Company (USA) Basic Information List

Table Eli Lilly and Company (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly and Company (USA) Anti-angiogenic Agent Sales Market Share (2011-2016)

Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Basic Information List

Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Sales Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information List

Table Abbott Laboratories (USA) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott Laboratories (USA) Anti-angiogenic Agent Sales Market Share (2011-2016)

Table AstraZeneca Plc. (UK) Basic Information List

Table AstraZeneca Plc. (UK) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Plc. (UK) Anti-angiogenic Agent Sales Market Share (2011-2016)

Table Meditrina Pharmaceuticals, Inc. (US) Basic Information List

Table Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

Table Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Sales Market Share (2011-2016)

Table Neurocrine Biosciences, Inc. (US) Basic Information List

Table Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Sales Market Share (2011-2016)

Table AEterna Zentaris, Inc. (Canada) Basic Information List

Table AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Sales, Revenue, Price and Gross Margin (2011-2016)

Table AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Anti-angiogenic Agent

Figure Manufacturing Process Analysis of Anti-angiogenic Agent

Figure Anti-angiogenic Agent Industrial Chain Analysis

Table Raw Materials Sources of Anti-angiogenic Agent Major Manufacturers in 2015

Table Major Buyers of Anti-angiogenic Agent

Table Distributors/Traders List

Figure United States Anti-angiogenic Agent Production and Growth Rate Forecast (2016-2021)

Figure United States Anti-angiogenic Agent Revenue and Growth Rate Forecast (2016-2021)

Table United States Anti-angiogenic Agent Production Forecast by Type (2016-2021)

Table United States Anti-angiogenic Agent Consumption Forecast by Application (2016-2021)